Clinical Trials Browser

Terminated × Lymphoma, B-Cell, Marginal Zone × LFB-R603 × Clear all

NCT04806035 2024-07-31

Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Phase 1 Terminated

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone